OR WAIT null SECS
July 16, 2012
It’s been a few months since the Obama administration launched the Big Data Research and Development Initiative, aimed at pooling large collections of data to gain knowledge and insight into everything from national security to the environment to biomedical research.
July 11, 2012
This week, KV Pharmaceuticals filed a lawsuit against FDA to force the agency to stop compounded versions of their synthetic progesterone drug, Makena (hydroxyprogesterone caproate), from being produced.
July 09, 2012
Continuous manufacturing is the way of the future for solid-dosage pharmaceuticals, but one of the challenges for implementation is how to define a batch for quality assurance testing.
July 03, 2012
The recent announcement that GlaxoSmithKline will pay a record $3 billion in civil and criminal penalties marks the largest settlement ever incurred by a drug company,
July 02, 2012
Developments in hot-melt extrusion using twin-screw extruders to make solid-dosage drug forms.
June 30, 2012
Last week, I looked at a consultation in the UK concerning access to unlicensed medicines.
June 29, 2012
This guest blog was written by Christie Bloomquist is a partner in health practice at Hogan Lovells, a global legal practice firm based in Washington DC.
The main result of the Supreme Court decision upholding the Affordable Care Act (ACA) is that it ends all the rampant speculation and uncertainty about the future shape of the U.S. health care system.
June 27, 2012
Roche’s recent announcement that it will be closing its venerable Nutlley, NJ R&D site is the latest in a string of mergers and reorganizations that have resulted in the loss of thousands of life-sciences jobs from New Jersey,
June 26, 2012
A coordinated European programme was recently carried out involving routine inspections of pharmaceutical companies’ safety reporting systems.